Trifluoperazine Hcl (trifluoperazine HCl)
Last reviewed · Source: First Databank (FDB) drug data
Overview
Trifluoperazine hydrochloride is a phenothiazine antipsychotic agent.
USES: This medication is used to treat certain mental/mood disorders (such as schizophrenia, psychotic disorders). Trifluoperazine belongs to a class of drugs known as antipsychotics. It works by helping to restore the balance of certain natural substances in the brain.
Generic name: trifluoperazine HCl
Pronunciation: (TRYE-floo-oh-PER-a-zeen)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Trifluoperazine Hcl
Indications
The following indications are listed for Trifluoperazine Hcl:
- Anxiety
- Schizophrenia
Also known as: Dementia Praecox, Parergasia.
Dosing
Dosage of trifluoperazine hydrochloride is expressed in terms of trifluoperazine. Dosage must be carefully adjusted according to individual requirements and response, using the lowest possible effective dosage. Dosage should be increased more gradually in debilitated, emaciated, or geriatric patients. Since geriatric patients may be more susceptible to hypotension and neuromuscular reactions, these patients should be observed closely; in general, dosages in the lower end of the range are sufficient for most geriatric patients. Because of the long duration of action of trifluoperazine, patients may be controlled with twice-daily dosing; in some patients, once-daily dosing may be adequate. Optimum therapeutic response usually occurs within 2-3 weeks. After the maximum response is attained, dosage should be reduced gradually to the minimum effective level for maintenance. Because of the risk of adverse reactions associated with cumulative effects of phenothiazines, patients with a history of long-term therapy with trifluoperazine and/or other antipsychotic agents should be evaluated periodically to determine whether maintenance dosage could be decreased or drug therapy discontinued.
Trifluoperazine hydrochloride is administered orally. The drug also has been administered IM+, but a parenteral dosage form is no longer commercially available in the US.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.